Triple
T7238523
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Basel metropolitan area |
E155293
|
entity |
| Predicate | hasPharmaceuticalCompany |
P19182
|
FINISHED |
| Object | Novartis |
E141505
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Novartis | Statement: [Basel metropolitan area, hasPharmaceuticalCompany, Novartis]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Novartis Context triple: [Basel metropolitan area, hasPharmaceuticalCompany, Novartis]
-
A.
Novartis
chosen
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
B.
Roche
Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
-
C.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
D.
Sandoz
Sandoz is a historic Swiss pharmaceutical company best known as a predecessor of Novartis and a major player in generic medicines.
-
E.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company known for developing and manufacturing innovative medicines in areas such as oncology, immunology, and cardiovascular disease.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasPharmaceuticalCompany Context triple: [Basel metropolitan area, hasPharmaceuticalCompany, Novartis]
-
A.
hasIndustrialCompany
Indicates that one entity possesses, controls, or is associated with an industrial company.
-
B.
hasMediaCompany
Indicates that one entity owns, controls, or is formally associated with a media company.
-
C.
isMajorCompanyIn
Indicates that a company is a leading or dominant business entity within a specified country, region, or market.
-
D.
hasNotableCompany
chosen
Indicates that an entity is associated with or linked to a company that is considered notable or significant in some context.
-
E.
hasAssociatedCompany
Indicates that one entity is linked or connected to a company in an associated or affiliated manner.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c688143bfc81908d4176617735e601 |
completed | March 27, 2026, 1:37 p.m. |
| NER | Named-entity recognition | batch_69c6ea552a688190a00f5d0ad982f787 |
completed | March 27, 2026, 8:36 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c7cc381a4081909a8ea7ee02348328 |
completed | March 28, 2026, 12:40 p.m. |
| PD | Predicate disambiguation | batch_69c6e7644648819096a5e2de5d0dbe97 |
completed | March 27, 2026, 8:24 p.m. |
Created at: March 27, 2026, 2:55 p.m.